What is the official ID of this bill?
The official print number for this legislation is HR 2846.
Cheaper Medicines for Seniors: New Medicare Rules
New regulations aim to make it easier for seniors to access lower-cost generic and biosimilar medicines under the Medicare program. Insurance companies will be required to offer these drugs at lower prices and without excessive restrictions, potentially reducing treatment costs for many.
Key points
Medicare Part D insurance plans must include lower-cost generic and biosimilar drugs on their formularies.
Access to these cheaper drugs cannot be more restricted than access to their more expensive brand-name counterparts.
Insurance companies must create specific pricing tiers for generic and biosimilar drugs with lower co-payments to encourage their use.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.